跳至主要内容
临床试验/NL-OMON51842
NL-OMON51842招募中不适用

Dual-AntiPlatelet Therapy strategies FOR elective PCI in a REAL-world setting - DAPT for REA

Amsterdam UMC0 个研究点目标入组 1,462 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,462

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Adult men and women aged at least 18 years
  • - Scheduled for diagnostic CAG due to suspected obstructive coronary artery

排除标准

  • - Inability to give informed consent (e.g., language barrier)
  • - Presence of contra-indications for the use of clopidogrel
  • - Patients using clopidogrel for other reasons than the scheduled diagnostic
  • - Patients using P2Y12 inhibitors other than clopidogrel
  • - Patients using VKA
  • - Patients using DOAC/NOAC

研究者

发起方
Amsterdam UMC

相似试验